Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Multicenter: Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response

NCT01128803 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT01128803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01128803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Multicenter: Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response
Lead sponsor
Nantes University Hospital
Phase
Phase 1/2
Overall status
Terminated
Start date
October 31, 2009
Completion date
October 31, 2010
Enrollment
1 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma